title: Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome.
abstract: Abnormalities of nitric oxide metabolism have been implicated in the pathogenesis of acute chest syndrome in subjects with sickle cell anemia. It is not known whether exhaled nitric oxide levels (FE(NO)) are abnormal in children with a history of the acute chest syndrome (ACS). We compared FE(NO), plasma nitric oxide metabolites (NO(x)), serum arginine and citrulline levels, and the number of AAT repeats in intron 20 of NOS I in subjects with sickle cell disease (SCD) and a history of at least one episode of ACS (ACS(+), n = 13), subjects with SCD and no prior history of ACS (ACS(-), n = 7), and healthy children (HC, n = 6). Mean +/- SD FE(NO) (ppb) was lower in ACS(+) than in ACS(-) and HC: (10.4 +/- 4.3 versus 23.4 +/- 6.1 p = 0.002] and 30.4 +/- 15.8 [p = 0.0001], respectively). Plasma NO(x) (microM) were similar in all three groups (37.3 +/- 19.4, 33.0 +/- 13.2, 44.7 +/- 7.8, respectively). Arginine and citrulline levels (microM) did not differ between ACS(+) and ACS(-) groups. Spirometric data revealed a mildly diminished FEV(1) and FVC in ACS(+) that was statistically different from HC but not ACS(-): (FEV(1) as % of predicted for ACS(+), ACS(-), and HC; 83 +/- 17 versus 87 +/- 16 versus 102 +/- 16, respectively, p < 0.05 between ACS(+) and HC). The level of FE(NO) was significantly associated with the sum of AAT repeats in intron 20 of NOS I gene alleles. The correlation coefficient (r) was 0.62 (p < 0.005). We conclude that FE(NO) levels are significantly reduced in subjects who have a history of ACS and that the FE(NO) levels are significantly correlated with the number of NOS I AAT repeats. FE(NO) is a sensitive marker and may be a predictor of ACS prone children.
authors.affiliation: Nemours Children's Clinic, Jacksonville, Florida, USA.
authors.forename: K J
authors.initials: KJ
authors.lastname: Sullivan
authors.forename: N
authors.initials: N
authors.lastname: Kissoon
authors.forename: L J
authors.initials: LJ
authors.lastname: Duckworth
authors.forename: E
authors.initials: E
authors.lastname: Sandler
authors.forename: B
authors.initials: B
authors.lastname: Freeman
authors.forename: E
authors.initials: E
authors.lastname: Bayne
authors.forename: J E
authors.initials: JE
authors.lastname: Sylvester
authors.forename: J J
authors.initials: JJ
authors.lastname: Lima
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000150:complications / Q000235:genetics* / Q000378:metabolism; D001120:Arginine / Q000097:blood; D001944:Breath Tests; D002648:Child; D002956:Citrulline / Q000097:blood; D005541:Forced Expiratory Volume; D005838:Genotype; D006801:Humans; D008171:Lung Diseases / Q000150:complications / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D009566:Nitrates / Q000097:blood; D009569:Nitric Oxide / Q000032:analysis*; D019001:Nitric Oxide Synthase / Q000235:genetics*; D052248:Nitric Oxide Synthase Type I; D009573:Nitrites / Q000097:blood; D011110:Polymorphism, Genetic; D013577:Syndrome; D018911:Trinucleotide Repeats; D014797:Vital Capacity
chemical_list: D009566:Nitrates; D009573:Nitrites; D002956:Citrulline; D009569:Nitric Oxide; D001120:Arginine; C496320:NOS1 protein, human; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I